EXELIXIS INC EXEL (NASDAQ) $ 2.98 Change: -0.02 -0.67% | Volume: 824,674
Sponsored by Click here!

EXELIXIS INC - Fundamental Profile

Company Information

Ticker Symbol: EXEL
Exchange: NASD
Contact Info: 170 Harbor Way South San Francisco CA 94083 650 837-7000
CEO/President: Vincent Marchesi M
Industry: Medical - Biomedical / Standard Industry Code: 8731
Description: Exelixis Inc. is a leader in the fields of model system genetics andcomparative genomics. These fields involve the systematic study of simpleorganisms, such as fruit flies, nematodes, mice, zebrafish and simple plants, to rapidly and efficiently determine gene function and establish its commercial utility in humans and other commercially important biological systems. The proprietary technologies provide a rapid, efficient and cost-effective way to move beyond DNA sequence data to understand the function of genes and the proteins that they encode.

Share Information

Shares Outstanding: 106,650 (000) Market Value: 325,290 ($000)
Percentage of Inst.Shareholders: 86.33% Number of Inst.Shareholders: 6.41%
Last Quarter Sales: 29.93 ($Mil.) Last Quarter Net Income: -38.51 ($Mil.)
Last Quarter EPS: -0.39 P/E Ratio: 0
Most Recent Earnings: -0.36 on 10/27/08 Earnings Per Share: -1.37
Most Recent Split: Annual Dividend Rate: 0
Most Recent Dividend: Annual Dividend Yield: 0%
Data Provided By Barchart.com
CoreData does not represent, warrant, or guarantee completeness, accuracy or timeliness of its data, and shall have no liability of any kind whatsoever to any party on account of any incompleteness of, inaccuracies in or untimeliness of the CoreData content provided hereunder, or for any delay in reporting such data. CoreData expressly disclaims all warranties of fitness of the CoreData content or computations and analyses thereof for a particular purpose or use.
advertisement

Top Competitors

AMGEN +12.60 58.23
GILEAD SCIENCES -1.00 46.92
CELGENE CP -10.00 58.86
BIOGEN IDEC INC -31.90 43.52
AMYLIN PHARMA I -85.70 6.41